• PTBP2 Attenuation Enhances Direct Fibroblast-to-Neuron Conve

  2026-05-23

  The reference study demonstrates that reducing PTBP2 expression markedly improves the efficiency of converting human skin fibroblasts into induced neurons by promoting neuron-specific alternative splicing, particularly in synergy with RBFOX3. These findings provide mechanistic insight into cellular reprogramming strategies for neurodegenerative disease research and highlight alternative splicing modulation as a key axis for direct lineage conversion.

• Adefovir Dipivoxil: Advances in Chronic Hepatitis B Therapy

  2026-05-22

  Hadziyannis and Papatheodoridis's review delineates the clinical and mechanistic advances enabled by adefovir dipivoxil (GS-0393) in treating chronic hepatitis B, highlighting its efficacy in both wild-type and lamivudine-resistant HBV. Their analysis provides foundational evidence for the compound's long-term safety profile and its significance as a nucleotide analog antiviral.

• Pazopanib Hydrochloride: Optimizing Anti-Angiogenic Assays

  2026-05-22

  Pazopanib Hydrochloride (GW786034) empowers cancer research with robust multi-target kinase inhibition, enabling precise dissection of angiogenesis and tumor growth pathways. This guide details advanced experimental workflows, troubleshooting strategies, and actionable insights to unleash the full potential of Pazopanib in preclinical oncology models.

• ISRIB (trans-isomer): Novel Insights for Cognitive Memory an

  2026-05-21

  Discover how ISRIB (trans-isomer), a potent PERK inhibitor, offers unique advantages for dissecting neuroinflammation and memory loss. This article unpacks new experimental evidence and practical assay guidance for cognitive and neurodegenerative disease research.

• MitMAB in Translational Endocytosis: Mechanistic Precision f

  2026-05-21

  This thought-leadership article explores how MitMAB, a potent dynamin GTPase inhibitor, is transforming endocytosis and membrane trafficking research in advanced organoid models. Drawing from recent breakthroughs in milk-derived extracellular vesicle uptake, we map the intersection of mechanistic insight and strategic protocol guidance, highlighting MitMAB’s unique value for translational researchers seeking reproducibility and physiologic relevance.

• Lactate-GPR81/FARP1 Axis Drives Insulin-Independent Glucose

  2026-05-20

  This study identifies the lactate-activated GPR81/FARP1 signaling pathway as a critical regulator of insulin-independent glucose uptake in skeletal muscle. By elucidating the mechanism underlying exercise-induced glycemic control, it opens new avenues for metabolic disease intervention beyond insulin-centric therapies.

• Indometacin Sodium in Preventing Premature Ovulation: IVF RC

  2026-05-20

  This article examines a randomized controlled trial evaluating the efficacy of indometacin sodium in reducing premature ovulation during modified natural-cycle IVF. The findings highlight nuanced effects, particularly in specific patient subgroups, and inform the design of anti-inflammatory research assays involving prostaglandin synthesis inhibition.

• CAV-1-Mediated Mitochondrial Cholesterol and Mitophagy in Li

  2026-05-19

  This study delineates how celastrol suppresses liver cancer by disrupting CAV-1/SCP2-mediated mitochondrial cholesterol metabolism, thereby triggering mitophagy. The findings highlight the therapeutic potential of targeting organelle-specific lipid pathways in oncology.

• Strategic Leverage of BQCA for Precision M1 Receptor Modulat

  2026-05-19

  This thought-leadership article explores the mechanistic underpinnings and translational potential of Benzyl Quinolone Carboxylic Acid (BQCA) as a selective M1 muscarinic acetylcholine receptor modulator. We synthesize recent advances in GRK subtype bias, highlight best practices for experimental design, and offer strategic insights for translational researchers aiming to bridge molecular mechanisms to clinical solutions in cognitive and Alzheimer's disease research.

• (S)-Mephenytoin: CYP2C19 Substrate for Advanced Drug Metabol

  2026-05-18

  (S)-Mephenytoin is the gold-standard CYP2C19 substrate enabling high-fidelity modeling of human drug metabolism, especially in next-generation organoid-based systems. This guide translates recent breakthroughs into actionable workflows, protocol refinements, and troubleshooting strategies for reproducible, data-driven research.

• 2'3'-cGAMP (Sodium Salt): Redefining the STING Research Fron

  2026-05-18

  Explore how 2'3'-cGAMP (sodium salt) from APExBIO is revolutionizing translational research into the cGAS-STING pathway. This article bridges mechanistic understanding with strategic experimental guidance, synthesizing new findings—including the metabolic implications of STING activation—to inform next-generation immunology and oncology workflows.

• CB-5083 (SKU B6032): Enabling Robust p97 Inhibition in Cell

  2026-05-17

  This article explores how CB-5083 (SKU B6032), a highly selective and potent p97 inhibitor, empowers biomedical researchers to achieve reproducible disruption of protein homeostasis and reliable cancer cell apoptosis induction. Using scenario-driven Q&A, we address real laboratory challenges, protocol optimization, and product selection, grounded in quantitative literature and best practices for CB-5083.

• Rotavirus Suppresses Nrf2-Mediated Antioxidant Defenses in H

  2026-05-16

  This study reveals that progressive rotavirus infection leads to the sharp downregulation of the redox-sensitive transcription factor Nrf2 and its cytoprotective target genes, despite initial transient activation. The work provides mechanistic insight into viral strategies for subverting host oxidative stress responses, highlighting new directions for therapeutic modulation of redox homeostasis.

• Gene Regulatory Network Analysis Identifies OTX2 and LMX1A a

  2026-05-15

  This study introduces an integrative gene regulatory network (GRN) analysis to systematically identify critical transcription factors in the direct conversion of human fibroblasts to neurons. Experimental validation reveals OTX2 and LMX1A as essential regulators, providing mechanistic insights that can refine cellular reprogramming protocols and improve induced neuron (iN) generation for disease modeling.

• Forskolin: Adenylate Cyclase Activator in Advanced Research

  2026-05-15

  Forskolin stands out as a gold-standard adenylate cyclase activator, enabling precise cAMP modulation in stem cell, neuronal, and virology models. This guide unpacks actionable protocols, cross-domain applications, and troubleshooting strategies for maximizing Forskolin’s research impact.

8243 records 20/550 page Previous Next First page 上5页 1617181920 下5页 Last page